Walter Kaufmann

Director of Rett Syndrome Program
Boston Children's Hospital

From this contributor

By Walter Kaufmann

9 May 2018

5 min read

Intellectual disability’s introduction in the DSM-5: What’s the impact?

The move to replace ‘mental retardation’ with ‘intellectual disability’ is widely accepted, but little data exist on the impact of this change.

Spectrum

Intellectual disability’s introduction in the DSM-5: What’s the impact?

By Walter Kaufmann

9 May 2018 | 5 min read

Spectrum

By Walter Kaufmann

30 May 2013

3 min read

Intellectual disability’s DSM-5 debut

The newest edition of the Diagnostic and Statistical Manual of Mental Disorders relies on intellectual function in daily life, both for diagnosing intellectual disability and for determining its level of severity, says Walter Kaufmann.

Spectrum

Intellectual disability’s DSM-5 debut

By Walter Kaufmann

30 May 2013 | 3 min read

Explore more from The Transmitter

Treatments

By Calli McMurray

2 June 2026

5 min read

Research image of brain cells involved with Amyotrophic lateral sclerosis (ALS) illuminated through genetic tools

Allen Institute sets sights on treatments for five brain diseases

The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.

Treatments